Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melatonin for the Treatment of Developmental/Epileptic Encephalopathy With Spike Wave Activation In Sleep (DEE-SWAS; Formerly ESES)

NCT07221968 is registered in ClinicalTrials.gov with Hugo W. Moser Research Institute at Kennedy Krieger, Inc. as lead sponsor.

NCT NCT07221968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07221968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melatonin for the Treatment of Developmental/Epileptic Encephalopathy With Spike Wave Activation In Sleep (DEE-SWAS; Formerly ESES)
Lead sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
December 30, 2028
Enrollment
3 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

csws, developmental and/or epileptic encephalopathies, electrical status epilepticus in sleep